VectorY Therapeutics is a clinical-stage biotechnology company developing novel genetic medicines for neurodegenerative diseases using its proprietary Vectorized Antibody Platform, which combines AAV-based gene delivery with antibody engineering to express therapeutic antibodies directly in the central nervous system. - View it on GitHub